Leggett & Platt (LEG) — Potential Buyout — 22%+ Upside

Current Price: $9.84

Target Price: $12+

Upside: 22%+

Expected Timeline: July-August 2026

Bedding components manufacturer Leggett & Platt has received a non-binding $12/share buyout offer from mattress giant Somnigroup (formerly Tempur Sealy). LEG’s board decided the price was too low, but granted SGI a six-month due diligence period running through mid-July. Roughly half of that window has already passed, and LEG’s stock has been on a pretty wild ride along the way.

Over the last six weeks, the market has gone from enthusiastically pricing in a sizable bump (LEG traded above $12/share for quite some time) to seriously doubting whether the deal will close at all. The spread has now widened to 22%, with the stock returning to pre-announcement levels. That’s a pretty wild swing, and I think the market may have over-reacted.

There have been no real updates on the due diligence process, beyond that it remains ongoing. This massive spread move appears to have been driven by LEG’s soft quarterly earnings and 2026 guidance (Feb 11), along with broader market turbulence.

LEG’s Q4’25 results were not particularly surprising. Another weak quarter, as the industry remains in a post-COVID downturn. More importantly, the guidance provided in Q3 was met, and the outlook for 2026 was broadly flat, which simply implied that near-term recovery is unlikely. I don’t think this 2026 outlook gave Somnigroup any new information or changed its plans regarding the offer.

The deal still appears to be alive. The most telling sign is SGI’s investor day on March 4, in which LEG received quite a bit of spotlight. At the time, SGI was already 1.5 months into the due diligence, and LEG’s Q4 results were also out. If any doubts regarding this deal had started to creep in for Somnigroup, it could have easily stayed quiet and simply pointed to the “ongoing process” in response to any analyst questions.

Instead, the chairman leaned into it voluntarily and spent time laying out how attractive, synergistic, and how fitting LEG is for SGI’s broader strategy:

I want to touch briefly on another strategic initiative that we’ve announced, which you’re likely tracking. We’ve submitted a proposal to acquire Leggett & Platt in an all-stock transaction, which values the company at $12 per share. […]

The strategic rationale here is straightforward, vertical integration, Leggett & Platt is a key supplier to the bedding industry. They supply critical inputs like innerspring units, specialty foam and other components to the bedding producers globally. By bringing Leggett & Platt into Somnigroup’s fold, we’d further strengthen our value chain advantages, unlock additional synergies and enhance our competitive position. We’re currently conducting due diligence and our active discussions with Leggett & Platt’s board. There is no certainty that these discussions will ultimately lead to a transaction. But I wanted to flag it for you because it’s consistent with our overall M&A strategy, build scale, capturing efficiencies, creating long-term shareholder value through disciplined accretive transaction.

That is not how you talk about an acquisition you are starting to get cold feet on. LEG came up a few more times during the call. At one point, an analyst asked whether the company could absorb two fairly sizable transactions in a short period (including the recently closed Mattress Firm). The chairman’s response was “we’re ready to do more.”

At the very least, this suggests the due diligence process was going smoothly and SGI’s enthusiasm for the acquisition of LEG was definitely still there several weeks ago.

SGI is a strategic buyer and is unlikely to anchor its decision on short-term stock volatility. It is the largest mattress manufacturer in the US and is building a vertically integrated platform, having recently acquired the largest mattress retailer Mattress Firm. Taking over LEG would bring a key supplier in-house and generate meaningful additional synergies.

The acquisition would also improve SGI competitive standing as pointed out by this VIC author in December:

This move for SGI will continue to cripple Serta Simmons Bedding (SSB), the second largest player in U.S. bedding. LEG is SSB’s largest supplier. SGI already dealt SSB a body blow by acquiring Mattress Firm earlier this year, SSB’s largest customer. Unsurprisingly, SGI has quickly moved to reduce third-party slots from the Mattress Firm floor in favor of their own brands or brands like Purple and Kingsdown, which SGI recently acquired a 25% equity stake in. Depending on how much of LEG’s capacity can move over to supporting SGI’s needs, this acquisition could be a knockout punch for SSB.

The market clearly likes Somnigroup’s vertical integration story, and the buyer’s valuation reflects that. SGI is trading at 23x 2026E P/E. That likely gives the buyer’s management an extra incentive to push the takeover forward and keep feeding into the integration narrative. At the same time, the deal looks quite accretive on paper, with LEG being acquired at 10.4x 2026E P/E.

As for LEG itself, the board has allowed the due diligence process to move forward. Shortly after receiving the offer, the company also put in place retention packages for senior executives, with clawbacks that would fall away upon a change of control. That is usually not what you do if a sale is off the table, and suggests the board is probably open to a transaction.

So there is quite a bit to this setup that I find attractive, especially with the spread now as wide as it is. That said, it is not free money and there are several points worth considering:

#1: While LEG stock is already back to the pre-announcement levels, the shares could still probably fall another 10%–20% if there is no deal (SGI itself is down 20% over the period). It’s not a zero downside setup. Nonetheless, the market seems to be pricing in ~50% chance of success right now, which kind of seems too low.

#2: It’s still possible that the parties do not agree on price. LEG explicitly said that $12 undervalues the company, while SGI had refused to raise its offer pre-due diligence, maintaining that it was fair. Recent market turbulence cuts both ways. On one hand, LEG may be in a weaker position to push for a meaningful raise, so a token-sized bump could be enough for its board to save face. On the other hand, the $12/share consideration is to come in SGI’s stock (with the ratio to be fixed at a later date). The buyer’s shares are down ~20% since the offer announcement, which means it would need to issue more shares to fund the same $12, let alone a higher offer. What helps a bit is that LEG is not a crazy large deal in this context, at $2.6bn EV versus SGI’s $15.5bn market cap, and that the buyer’s stock is still highly valued.

#3: The outcome of due diligence is also bit of a wild card. LEG operates three segments of similar size, and bedding is only one of them (see the slide below). SGI is likely interested only in the bedding segment and would look to divest the other two. It probably already has a solid understanding of the bedding business, so the odds of any negative surprises here are lower. The bigger risk is that something bad comes up during the due diligence of the other two segments: Specialized Products and Furniture, Flooring & Textile. For what it’s worth, historically, these segments have been very stable and seem to have largely returned to pre-COVID levels already. 2026 guidance for these segments was also broadly flat, with volumes down low single digits in Specialized Products and flat in Furniture, Flooring and Textile Products.

#4: LEG’s management owns a minimal amount of stock, and might be more interested in keeping their positions than selling the company. That said, board members are not particularly young (60s-70s mostly) and many senior executives would receive meaningful compensation under a change of control.

#5: Finally, there may be some regulatory risk. The FTC challenged SGI’s Mattress Firm deal, arguing it could harm competition in the “premium mattresses” market, as SGI could limit rivals’ access to Mattress Firm’s nationwide network, reducing consumer choice and potentially raising prices. Judge Eskridge’s 115-page opinion rejected this claim on every front. The court found the FTC’s narrow “premium mattress” market definition to be arbitrary and inconsistent with commercial realities. It also concluded that the merger was unlikely to harm competition, noting that rivals have multiple alternative distribution channels, along with SGI’s commitments to divest certain stores and reserve shelf space for third-party brands for five years. In theory, the FTC could still challenge the LEG transaction on similar grounds. However, LEG is half the size of Mattress Firm, and it is unclear whether the agency would be willing to risk another high-profile loss against the same company in a short time span. Still, the risk is not zero, and even if a binding agreement is signed, the spread may not tighten to minimal levels straightaway.

More information on LEG’s businesses and historical financials can be found in this fresh investor deck from last month.